A membrane-bound cytochrome b, a heterodimer formed by a 91-kD glycoprotein and a 22-kD polypeptide, is a critical component of the phagocyte NADPH-oxidase responsible for the generation of superoxide anion. Mutations in the gene for the 91-kD chain of this cytochrome result in the X-linked form of chronic granulomatous disease (CGD), in which phagocytes are unable to produce superoxide. Typically, there is a marked deficiency of the 91-kD subunit and the cytochrome spectrum is absent (X-CGD). In a variant form of CGD with X-linked inheritance, affected males have a normal visible absorbance spectrum of cytochrome b, yet fail to generate superxoxide (X+ CGD). The size and abundance of the mRNA for the 91-kD subunit and its encoded protein were examined and appeared normal. To search for a putative mutation in the coding sequence of the 91-kD subunit gene, the corresponding RNA from an affected X+ male was amplified by the polymerase chain reaction and sequenced. A single nucleotide change, a C -> A transversion, was identified that predicts a nonconservative Pro --His substitution at residue 415 of the encoded protein. Hybridization of amplified genomic DNA with allelespecific oligonucleotide probes demonstrated the mutation to be specific to affected X+ males and the carrier state. These results strengthen the concept that all X-linked CGD relates to mutations affecting the expression or structure of the 91-kD cytochrome b subunit. The mechanism by which the Pro 415 -> His mutation renders the oxidase nonfunctional is unknown, but may involve an impaired interaction with other components of the oxidase.
Introduction
An unusual b-type cytochrome is an essential component of the phagocyte NADPH-oxidase, a membrane-bound enzyme system that generates large quantities of superoxide upon actiThis work was published in abstract form (1989. Clin. Res. 37:544a).
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Receivedfor publication 27 July 1989 and in revisedform 24 August 1989. vation by a variety of particulate and soluble stimuli (1). The superoxide radical is converted into other potent microbicidal oxidants used to kill ingested microorganisms. Current evidence indicates that the oxidase is formed by multiple components that include a membrane-associated cytochrome b as well as several cytosolic proteins required for activity of the otherwise dormant oxidase (2-6). The cytochrome, a heterodimer of a 9 l-kD glycoprotein (heavy chain) and 22 -kD polypeptide (light chain) (7, 8) , has a very low midpoint potential (-245 mV) and is postulated to function as the terminal redox carrier in the transfer of electrons from NADPH to oxygen (1).
In the inherited disorder chronic granulomatous disease (CGD),' phagocytic cells are unable to generate superoxide (1, 9). Affected individuals develop severe and recurrent infections due to the lack of this important host antimicrobial pathway. CGD is genetically heterogenous, reflecting lesions in different components of the phagocyte oxidase (4-6, [10] [11] [12] . The X-linked recessive form, which includes the majority of cases, results from mutations in the gene encoding the 91-kD subunit of the cytochrome b heterodimer (2, 3, 12) . This accounts for the consistent absence of the cytochrome b heme spectrum previously noted in virtually all cases of Xlinked CGD (13) . Both the 91-and 22-kD chains are lacking in X-linked CGD despite the genetic deficiency of only the heavy chain, which suggests that the intracellular stability of the 22-kD species requires expression of the larger subunit (2, 7, 8).
The underlying defects in the gene for the 9 1-kD heavy chain that result in X-linked CGD appear to be heterogenous, but are largely unknown. Partial deletions ofthe gene, which is located at Xp21 (14) , are rare (12) . Complete gene deletions are associated with more complex phenotypes that include Duchenne muscular dystrophy, retinitis pigmentosa, and the McLeod phenotype (12, 14, 15) . In the majority of typical cases of X-CGD, heavy chain gene structure is grossly normal by conventional Southern blot analysis (12) . Levels of the mRNA for the heavy chain are typically, although not always, markedly deficient, presumably due to mutations that adversely affect the expression or stability ofthe mRNA ( 12, 16) .
Rare variant forms ofCGD with X-linked inheritance have been reported in which residual cytochrome b spectral activity is measurable (17) (18) (19) Western blot analysis. Western blots of neutrophil extracts were performed as described (2). Antiserum for the 9 l-kD heavy chain was prepared against a B-galactosidase fusion protein containing nearly the complete coding sequence of the heavy chain (2). Antiserum for the 22-kD light chain was prepared as previously described (2) against a peptide (SNPPPRPPAEAR) derived from the COOH-terminal region of this protein.
Preparation of RNA and DNA. Mononuclear cells were obtained from peripheral blood by Ficoll-Paque sedimentation and RNA prepared by guanidine-HCl precipitation (12) . Genomic DNA was isolated from peripheral blood cell nuclei (20) .
Northern blot analysis. RNA samples were electrophoresed in 1% agarose formaldehyde gels, transferred to nitrocellulose, and hybridized with a 1,400 base pair Pst I-Eco RI fragment of the heavy chain cDNA labeled by random priming as described (12) .
DNA amplification. First strand cDNA synthesis was performed in 50 Ml containing 50 mM Tris pH 8.3, 50 mM KC1, 8 mM MgCI2, 500 MM of each dNTP, 10 mM dithiothreitol, 1,000 U/ml RNAsin, 40 Mg/ml oligo(dT)12-18, 1 Mg total cellular RNA, and 100 U of AMV reverse transcriptase. The mixture was incubated at 42°C for 60 min, then inactivated by heating to 67°C for 5 min. Overlapping cDNA fragments that span the 1.7-kb open reading frame of the 9 1-kD heavy chain transcript were then amplified by the polymerase chain reaction using three pairs of synthetic oligonucleotide primers derived from the heavy chain cDNA sequence (oligonucleotides 1, 2; 3, 4; 5, 6 in Table I ). For each pair of primers, 10 Ml of the first strand cDNA reaction was amplified in 100 ML as described (21) . Certain portions of coding sequence in the heavy chain gene (see below) were amplified directly from genomic DNA (21) using oligonucleotide primers derived from flanking intron sequence (oligonucleotides 7, 8; 9, 10 in Table I ). Oligonucleotides were synthesized with restriction enzyme sites at their 5' ends (Hind III or Bam HI) to facilitate cloning.
Analysis ofamplified target sequences. DNA fragments amplified from the coding region of9 I-kD heavy chain cDNA and from genomic DNA were cloned into M13 derivatives and sequenced by the dideoxynucleotide chain termination method (22) . Individual clones were pooled to prepare single-stranded template for sequencing to avoid potential artifacts due to nucleotide misincorporation in any single clone. Allele-specific oligonucleotide (ASO) probes (oligonucleotides 11, 12 in Table I ) for the mutation identified in the X+ CGD family and for the wild type sequence were used for direct screening of the corresponding exon (amplified from genomic DNA) in a slot blot format. The amplified DNA fragment was denatured with NaOH, immobilized on nitrocellulose, and hybridized with 32P end-labeled ASO (23) . Blots were washed in 6X standard saline citrate (0.9 M NaCl, 0.09 M sodium citrate, pH 7.5) at room temperature and then at 59°C for 10 min. (Fig. 1, lane 2) . The size and abundance of both the heavy and light chains of the cytochrome also appeared normal in a Western blot of X+ neutrophil extracts (Fig. 2, lane 2) , in contrast to the classic cytochrome-negative form of X-linked CGD in which both chains are markedly deficient (Fig. 2,  lane 3) . The sequence of the protein coding region of the cytochrome b heavy chain transcript in affected males in this family was determined in its entirety from cDNA derived from peripheral blood mononuclear cell RNA. Three overlapping segments of the 1.7-kb open reading frame of the heavy chain transcript were obtained by PCR amplification using specific primers (see Table I ). The initiator ATG lies only 11 nucleotides downstream from the cap site (2) and is encompassed within the most 5' synthetic oligonucleotide primer (primer 1 in Table I ). Therefore, to obtain the extreme 5' sequence, it was necessary to amplify genomic DNA using flanking intron primers (primers 7, 8; Table I ). Upon completion of this analysis, only a single nucleotide substitution, a C --A transversion at nucleotide 1,256 (Fig. 3) , was evident. This mutation predicts a nonconservative substitution of pro- line to histidine at residue 415 of the 570 amino acid heavy chain. The C A transversion might represent either a critical mutation in the 91-kD heavy chain or an irrelevant polymorphism. To address this issue, allele-specific oligonucleotide probes were used to examine the occurrence of the C A mutation in genomic DNA samples from 14 unrelated normal controls and 10 unrelated patients with classical X-CGD. Two brothers with the X+ variant form of CGD studied here and their parents were also analyzed by this approach. The exon in which the identified mutation occurs was amplified from genomic DNA (using primers 9, 10; Table I ) and analyzed by differential hybridization with each oftwo oligonucleotide probes, one for the wild type sequence (primer 1 1) and one for the mutation identified in the X+ variant (primer 12). The C --A mutation was found only in the two X+brothers and their mother, an obligate carrier (lanes 1, 3, 4 in Fig. 4) . The wild type allele was also present in their mother, consistent with the carrier state. The father carried the wild type allele-(lane 2, Fig. 4 ), as did all the normal controls (representative samples shown in lanes 5, 6; Fig. 4 ), and patients with X-CGD (not shown). (25, 26) has been reported to associate with the COOH terminus of the heavy chain (27) . This association appears to be required for complete phosphorylation of the 47-kD species, as only partial phosphorylation occurs in classic cytochrome-negative X-linked CGD (25, 28 
